1. Medtech Insight
  2. >>Policy & Regulation

CMS Removes Some Stark Law ‘Bureaucratic Barriers’ In Final Rule

Agency will permit exceptions from Stark Law for value-based arrangements involving advanced imaging referrals, donation of cybersecurity technology

 
• By Sue Darcey

The Stark Law ban on self-referrals wouldn’t apply to some physician owners of advanced imaging facilities under a CMS final rule.

Metallic Wrecking Ball Shattering The White Wall

Donations of cybersecurity equipment and physician referrals to advanced imaging facilities in which they have a financial interest will be allowed for value-based care under a new Centers for Medicare and Medicaid Services final rule on exceptions to the Stark Law.

The Stark physician self-referral law generally prohibits a physician from sending a patient to a facility that the physician fully or partially owns, is employed by, or from which the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Policy & Regulation

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By Ashley Yeo

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.